A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease requiring initiation of levodopa therapy.

Trial Profile

A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo in patients with Parkinson's disease requiring initiation of levodopa therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2015

At a glance

  • Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Adverse reactions
  • Acronyms STRIDE-PD
  • Most Recent Events

    • 07 Mar 2011 Last checked against ClinicalTrials.gov record.
    • 17 Feb 2009 Primary endpoint 'Time to disease progression' has not been met.
    • 17 Feb 2009 Status changed from active, no longer recruiting to completed, according to an Orion media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top